Medartis Holding AG (XSWX:MED) PE Ratio without NRI: 164.08 (As of Jun. 26, 2026) — Near Median


XSWX:MED Medartis Holding AG XSWX:MED
76 GF Score
Price CHF80.40
GF Value CHF105.66
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Medartis Holding AG PE Ratio without NRI?

Medartis Holding AG XSWX:MED +4.28% 76 PE Ratio without NRI is 164.08 as of Jun. 26, 2026, which is 2% below its 10-year median of 168.10. GuruFocus rates XSWX:MED with a GF Score™ of 76/100 and a GF Value™ of CHF105.66 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 448 Medical Devices & Instruments companies, Medartis Holding AG ranks worse than 95.09% on this metric.

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. As of today (2026-06-26), Medartis Holding AG's share price is CHF80.40. Medartis Holding AG's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was CHF0.49. Therefore, Medartis Holding AG's PE Ratio without NRI for today is 164.08.

During the past 12 years, Medartis Holding AG's highest PE Ratio without NRI was 1086.49. The lowest was 62.72. And the median was 168.10.

Medartis Holding AG's EPS without NRI for the six months ended in Dec. 2025 was CHF0.52. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was CHF0.49.

As of today (2026-06-26), Medartis Holding AG's share price is CHF80.40. Medartis Holding AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was CHF0.67. Therefore, Medartis Holding AG's PE Ratio (TTM) for today is 120.00.

Good Sign:

Medartis Holding AG stock PE Ratio (=110.6) is close to 5-year low of 106.38.

During the past years, Medartis Holding AG's highest PE Ratio (TTM) was 1788.00. The lowest was 99.50. And the median was 241.67.

Medartis Holding AG's EPS (Diluted) for the six months ended in Dec. 2025 was CHF0.79. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was CHF0.67.

Medartis Holding AG's EPS (Basic) for the six months ended in Dec. 2025 was CHF0.79. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was CHF0.67.


Medartis Holding AG  (XSWX:MED) PE Ratio without NRI Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio without NRI measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.


Medartis Holding AG PE Ratio without NRI Related Terms


Medartis Holding AG PE Ratio without NRI Historical Data

* Premium members only.

The historical data trend for Medartis Holding AG's PE Ratio without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medartis Holding AG PE Ratio without NRI Chart

Medartis Holding AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PE Ratio without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 224.48 At Loss 247.06 61.52 180.00

Medartis Holding AG Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
PE Ratio without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 247.06 At Loss 61.52 At Loss 180.00

XSWX:MED vs ABT, SYK, MDT: PE Ratio without NRI Comparison

For the Medical Devices subindustry, Medartis Holding AG's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medartis Holding AG PE Ratio without NRI vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medartis Holding AG's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Medartis Holding AG's PE Ratio without NRI falls into.


XSWX:MED
76GF Score
Medartis Holding AG XSWX:MED
PE Ratio without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medartis Holding AG PE Ratio without NRI Calculation

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. Regular PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than regular PE Ratio.

Medartis Holding AG's PE Ratio without NRI for today is calculated as

PE Ratio without NRI=Share Price/ EPS without NRI
=80.40/0.490
=164.08

Medartis Holding AG's Share Price of today is CHF80.40.
For company reported semi-annually, Medartis Holding AG's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF0.49.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months.

For Forward PE Ratio, the earnings are the expected earnings for the next twelve months.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.

Frequently Asked Questions Learn more about PE Ratio without NRI →
What does a PE Ratio without NRI of 164.08 mean?
Medartis Holding AG (XSWX:MED) has a PE Ratio without NRI of 164.08 as of Jun. 26, 2026. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on Medartis Holding AG and its competitors. This is near median its historical median of 168.10. Over the past decade, Medartis Holding AG's PE Ratio without NRI has ranged from 62.72 to 1,086.49. According to the industry distribution chart, Medartis Holding AG ranks #426 out of 448 companies in the Medical Devices & Instruments industry, placing it in the top 95.1%.
Is Medartis Holding AG's PE Ratio without NRI too high?
Medartis Holding AG's current PE Ratio without NRI of 164.08 is near median its 10-year median of 168.10. Over the past 10 years, this metric has ranged from a low of 62.72 to a high of 1,086.49. The Medical Devices & Instruments industry median PE Ratio without NRI is 23.09. Medartis Holding AG's value of 164.08 is 610.8% above this industry median. Based on the distribution chart, Medartis Holding AG ranks #426 out of 448 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Medartis Holding AG has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medartis Holding AG's PE Ratio without NRI compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medartis Holding AG ranks #426 out of 448 companies for PE Ratio without NRI. This places Medartis Holding AG in the lower half of its industry. The industry median PE Ratio without NRI is 23.09. Medartis Holding AG's value of 164.08 is 610.8% above this benchmark. Historically, Medartis Holding AG's own PE Ratio without NRI has ranged from 62.72 to 1,086.49 over the past decade. While the company's 10-year median is 168.10 vs. the industry median of 23.09, Medartis Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio without NRI for a Medical Devices & Instruments company?
The median PE Ratio without NRI among Medical Devices & Instruments companies is 23.09, based on 448 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio without NRI significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medartis Holding AG's current PE Ratio without NRI of 164.08 is 610.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio without NRI mean?
A high PE Ratio without NRI can signal that a stock is expensive relative to its fundamentals. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on Medartis Holding AG and its competitors. For the Medical Devices & Instruments industry, the median PE Ratio without NRI is 23.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medartis Holding AG's current PE Ratio without NRI is 164.08, which is near median its own 10-year median of 168.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medartis Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Medartis Holding AG (XSWX:MED) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF105.66, compared to a current price of CHF80.40 — trading 23.9% below its estimated fair value. The current PE Ratio without NRI is 164.08, which is near median its 10-year median of 168.10 and 610.8% above the Medical Devices & Instruments industry median of 23.09. Medartis Holding AG's overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio without NRI calculated?
PE Ratio without NRI is calculated from a company's financial statements. For Medartis Holding AG (XSWX:MED), the current PE Ratio without NRI is 164.08 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medartis Holding AG (XSWX:MED) Overvalued in 2026?

Based on GuruFocus' analysis, Medartis Holding AG stock appears to be undervalued. The current stock price of CHF80.40 is trading 23.9% below its estimated GF Value™ of CHF105.66. GuruFocus considers Medartis Holding AG to be Modestly Undervalued.

Key valuation signals for XSWX:MED:

  • PE Ratio without NRI: 164.08 (near median its 10-year median of 168.10)
  • GF Value™: CHF105.66 vs. price of CHF80.40 (23.9% below fair value)
  • GF Score™: 76/100 with 5 warning signs
  • Industry Position: 610.8% above the Medical Devices & Instruments median (#426 of 448)

No single metric tells the full story. See the XSWX:MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medartis Holding AG Business Description

Other Exchanges MEDz:UK1RU:Germany
Address Hochbergerstrasse 60E, Basel, CHE, 4057
Medartis Holding AG is a medical device company. The company's product profile is divided into APTUS products, StealthFix Products, and MODUS products. APTUS includes products for the Hand, Wrist, Elbow, Shoulder, and Foot. MODUS comprises products for the mandible. Geographically, it derives the majority of its revenue from Europe, Middle East and Africa (EMEA) and also has a presence in North America, Asia Pacific, and Latin America.
76GF Score

Get the complete analysis for XSWX:MED

PE Ratio without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF80.40
Price
CHF105.66
GF Value